FI971097A0 - Skopolaminplåster - Google Patents

Skopolaminplåster

Info

Publication number
FI971097A0
FI971097A0 FI971097A FI971097A FI971097A0 FI 971097 A0 FI971097 A0 FI 971097A0 FI 971097 A FI971097 A FI 971097A FI 971097 A FI971097 A FI 971097A FI 971097 A0 FI971097 A0 FI 971097A0
Authority
FI
Finland
Prior art keywords
scopolamine
saturation solubility
base
skopolamiinilaastari
patch
Prior art date
Application number
FI971097A
Other languages
English (en)
Finnish (fi)
Other versions
FI971097A (sv
FI118885B (sv
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4438989A external-priority patent/DE4438989C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI971097A publication Critical patent/FI971097A/sv
Publication of FI971097A0 publication Critical patent/FI971097A0/sv
Application granted granted Critical
Publication of FI118885B publication Critical patent/FI118885B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Fats And Perfumes (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI971097A 1994-09-16 1997-03-14 Skopolaminplåster FI118885B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4433004 1994-09-16
DE4433004 1994-09-16
DE4438989A DE4438989C2 (de) 1994-09-16 1994-10-31 Scopolaminpflaster
DE4438989 1994-10-31
EP9503555 1995-09-09
PCT/EP1995/003555 WO1996008251A1 (de) 1994-09-16 1995-09-09 Scopolaminpflaster

Publications (3)

Publication Number Publication Date
FI971097A FI971097A (sv) 1997-03-14
FI971097A0 true FI971097A0 (sv) 1997-03-14
FI118885B FI118885B (sv) 2008-04-30

Family

ID=25940173

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971097A FI118885B (sv) 1994-09-16 1997-03-14 Skopolaminplåster

Country Status (20)

Country Link
US (1) US5714162A (sv)
EP (1) EP0781134B9 (sv)
JP (1) JP4466977B2 (sv)
CN (1) CN1087938C (sv)
AT (1) ATE262333T1 (sv)
AU (1) AU695698B2 (sv)
CA (1) CA2200189C (sv)
CZ (1) CZ289313B6 (sv)
DE (1) DE59510883D1 (sv)
ES (1) ES2219665T3 (sv)
FI (1) FI118885B (sv)
HU (1) HUT77383A (sv)
IL (1) IL115189A (sv)
MX (1) MX9701968A (sv)
MY (1) MY112477A (sv)
NO (1) NO312496B1 (sv)
NZ (1) NZ292921A (sv)
PL (1) PL182158B1 (sv)
SK (1) SK282640B6 (sv)
WO (1) WO1996008251A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19738643C2 (de) * 1997-09-04 2001-10-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Scopolaminbase und Verfahren zu seiner Herstellung
US6087341A (en) * 1998-02-12 2000-07-11 The Board Of Trustees Of The Leland Standford Junior University Introduction of nucleic acid into skin cells by topical application
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
CA2440884C (en) * 2001-03-16 2012-05-22 Alza Corporation Transdermal patch for administering fentanyl
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
PL219512B1 (pl) * 2003-04-14 2015-05-29 Lohmann Therapie Syst Lts Plaster miejscowy, zastosowanie plastra miejscowego i sposób wytwarzania plastra miejscowego
WO2004093788A2 (en) * 2003-04-17 2004-11-04 The Trustees Of Columbia University In The City Ofnew York Desmoglein 4 is a novel gene involved in hair growth
WO2005105157A2 (en) * 2004-04-23 2005-11-10 The Trustees Of Columbia University In The City Ofnew York INHIBITION OF HAIRLESS PROTEIN mRNA
FR2884143B1 (fr) * 2005-04-08 2007-06-22 Millet Innovation Sa Timbre dermique rechargeable
US20070010550A1 (en) * 2005-07-08 2007-01-11 The Board Of Regents Of The University Of Texas Scopolamine to Reduce or Eliminate Hot Flashes, Night Sweats, and Insomnia
RU2008138595A (ru) * 2006-02-27 2010-04-10 Ноувен Фамэсьютикэлз, Инк. (US) Гибкая ограниченная система для трансдермального введения скополамина, способ ее изготовления и способ трансдермальной доставки скополамина с ее помощью
DE102006028987A1 (de) * 2006-06-24 2007-12-27 Lts Lohmann Therapie-Systeme Ag Ultraschallverstärktes transdermales therapeutisches System
RU2499583C2 (ru) * 2007-10-15 2013-11-27 Алза Корпорейшн Заместительное трансдермальное введение фентанила один раз в день
CN102764342B (zh) * 2012-07-17 2013-12-04 陈鼎汉 治疗褥疮、糖尿病伤口、烫伤的药膏
CA3133952A1 (en) * 2019-03-19 2020-09-24 Nobelpharma Co., Ltd. Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8104929A (nl) * 1980-11-12 1982-06-01 Alza Corp Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
US5310559A (en) * 1982-09-01 1994-05-10 Hercon Laboratories Corporation Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0356382B1 (de) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Mehrschichtiges Pflaster
US5176917A (en) * 1989-03-15 1993-01-05 Lts Lohmann Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
JPH04261119A (ja) * 1991-02-13 1992-09-17 Lintec Corp 経皮吸収型貼付剤

Also Published As

Publication number Publication date
ES2219665T3 (es) 2004-12-01
MX9701968A (es) 1998-02-28
CA2200189A1 (en) 1996-03-21
EP0781134A1 (de) 1997-07-02
EP0781134B9 (de) 2004-09-29
CZ75797A3 (en) 1997-07-16
JPH10505825A (ja) 1998-06-09
JP4466977B2 (ja) 2010-05-26
CZ289313B6 (cs) 2001-12-12
NO971203L (no) 1997-03-14
SK33897A3 (en) 1997-09-10
IL115189A (en) 1999-12-22
PL182158B1 (pl) 2001-11-30
CN1087938C (zh) 2002-07-24
AU3523195A (en) 1996-03-29
NO971203D0 (no) 1997-03-14
US5714162A (en) 1998-02-03
HUT77383A (hu) 1998-04-28
FI971097A (sv) 1997-03-14
FI118885B (sv) 2008-04-30
MY112477A (en) 2001-06-30
CA2200189C (en) 2008-06-17
EP0781134B1 (de) 2004-03-24
DE59510883D1 (de) 2004-04-29
SK282640B6 (sk) 2002-10-08
AU695698B2 (en) 1998-08-20
WO1996008251A1 (de) 1996-03-21
NO312496B1 (no) 2002-05-21
CN1158084A (zh) 1997-08-27
NZ292921A (en) 1998-09-24
IL115189A0 (en) 1995-12-31
ATE262333T1 (de) 2004-04-15
PL319259A1 (en) 1997-08-04

Similar Documents

Publication Publication Date Title
ATE262333T1 (de) Scopolaminpflaster
US6558695B2 (en) Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
ATE238778T1 (de) Transdermales therapeutisches system zur abgabe von hormonen
ATE258426T1 (de) Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen
ATE149349T1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
MY106628A (en) Estrogen-containing active substance plaster
DE69833000D1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
FI962770A (sv) Transdermal anordning, vilken innehåller polyvinylpyrrolidon som löslighet förbättrande medel
ATE204467T1 (de) Orale darreichungsform
ATE231388T1 (de) Lang wirksames mittel zur rektalen verabreichung
DE50014495D1 (de) Transdermales therapeutisches system mit einer selbstklebenden matrix, enthaltend organische säure-additionssalze von alkaloiden des morphin- bzw. morphinantyps
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan
DK0705085T3 (da) Molykylært transdermalt transportsystem
ATE294568T1 (de) Zusammensetzung zur behandlung von verbrennungen
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
RU95109228A (ru) Способ лечения трофических язв
DE69803607T2 (de) Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 118885

Country of ref document: FI

MM Patent lapsed